Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Un‐Yong Choi"'
Autor:
JeongHyun Shim, Kyoung‐Tae Kim, Kwang Gi Kim, Un‐Yong Choi, Jae Won Kyung, Seil Sohn, Sang Heon Lim, Hyemin Choi, Tae‐Keun Ahn, Hye Jeong Choi, Dong‐Eun Shin, Inbo Han
Publikováno v:
Stem Cells Translational Medicine, Vol 10, Iss 4, Pp 554-567 (2021)
Abstract Osteoporotic vertebral compression fractures (OVCFs) are serious health problems. We conducted a randomized, open‐label, phase I/IIa study to determine the feasibility, safety, and effectiveness of Wharton's jelly‐derived mesenchymal ste
Externí odkaz:
https://doaj.org/article/b18978a14c1f478f89d9aedf226a6368
Autor:
Manjunatha S. Muttigi, Byoung Ju Kim, Hemant Kumar, Sunghyun Park, Un Yong Choi, Inbo Han, Hansoo Park, Soo-Hong Lee
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-12 (2020)
Abstract Background Chronic low back pain is a prevalent disability, often caused by intervertebral disc (IVD) degeneration. Mesenchymal stem cell (MSC) therapy could be a safe and feasible option for repairing the degenerated disc. However, for succ
Externí odkaz:
https://doaj.org/article/51addbc50539465c8d04a0d804589602
Autor:
Tarek M. Bedair, Chang Kyu Lee, Da-Seul Kim, Seung-Woon Baek, Hanan M. Bedair, Hari Prasad Joshi, Un Yong Choi, Keun-Hong Park, Wooram Park, InBo Han, Dong Keun Han
Publikováno v:
Journal of Tissue Engineering, Vol 11 (2020)
Spinal fusion has become a common surgical technique to join two or more vertebrae to stabilize a damaged spine; however, the rate of pseudarthrosis (failure of fusion) is still high. To minimize pseudarthrosis, bone morphogenetic protein-2 (BMP2) ha
Externí odkaz:
https://doaj.org/article/6d86932ff39b4851a94bc5374e7bf908
Autor:
Kyoung-Tae Kim, Kwang Gi Kim, Un Yong Choi, Sang Heon Lim, Young Jae Kim, Seil Sohn, Seung Hun Sheen, Chan Yeong Heo, Inbo Han
Publikováno v:
Cells, Vol 9, Iss 10, p 2250 (2020)
The rates of pseudarthrosis remain high despite recent advances in bone graft substitutes for spinal fusion surgery. The aim of this single center, non-randomized, open-label clinical trial was to determine the feasibility of combined use of stromal
Externí odkaz:
https://doaj.org/article/95b45828d63741bc966c03d002379a03
Autor:
Kyung Hyun Kim, Dong Kyu Chin, Un-Yong Choi, Keun Su Kim, Jeong Yoon Park, Ga-On Park, Yong Eun Cho
Publikováno v:
The Nerve. 7:71-77
Objective: This study aimed to compare the radiographic and clinical outcomes between sacral alar iliac (SAI) screw fixation and conventional iliac (CI) screw fixation with a particular focus on the rate of reoperation, surgical site infection (SSI),
Autor:
Tae-Keun Ahn, Inbo Han, Hye Jeong Choi, Kwang Gi Kim, Dong-Eun Shin, Seil Sohn, JeongHyun Shim, Un-Yong Choi, Jae Won Kyung, Sang Heon Lim, Kyoung-Tae Kim, Hyemin Choi
Publikováno v:
Stem Cells Translational Medicine
Stem Cells Translational Medicine, Vol 10, Iss 4, Pp 554-567 (2021)
Stem Cells Translational Medicine, Vol 10, Iss 4, Pp 554-567 (2021)
Osteoporotic vertebral compression fractures (OVCFs) are serious health problems. We conducted a randomized, open‐label, phase I/IIa study to determine the feasibility, safety, and effectiveness of Wharton's jelly‐derived mesenchymal stem cells (
Autor:
Ye Won Kim, Hari Prasad Joshi, Un Yong Choi, Kyoung-Tae Kim, Su Yeon Kwon, Inbo Han, Eun Ji Roh, Juri Kim, Chul-Kyu Park, Seil Sohn, Hyemin Choi, Seung Hun Sheen, Jae Won Kyung, Yong Ho Kim, Hemant Kumar
Publikováno v:
Molecular Neurobiology. 58:424-438
Resolvins, a new family from the endogenous specialized pro-resolving mediators (SPMs), promote the resolution of the inflammatory response. Resolvin D3 (RvD3), a docosahexaenoic acid (DHA) product, has been known to suppress the inflammatory respons
Autor:
Sunghyun Park, Hemant Kumar, Inbo Han, Manjunatha S. Muttigi, Soo-Hong Lee, Byoung Ju Kim, Hansoo Park, Un Yong Choi
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-12 (2020)
Stem Cell Research & Therapy
Stem Cell Research & Therapy
Background Chronic low back pain is a prevalent disability, often caused by intervertebral disc (IVD) degeneration. Mesenchymal stem cell (MSC) therapy could be a safe and feasible option for repairing the degenerated disc. However, for successful tr
Publikováno v:
The Nerve. 5:18-21
Autor:
Samantha L. Payne, Jae Won Kyung, Inbo Han, Eun Ji Roh, Seil Sohn, Kyoung-Tae Kim, Michael J. Cooke, Su Yeon Kwon, Un Yong Choi, Molly S. Shoichet, Hyemin Choi, Hari Prasad Joshi
Publikováno v:
International Journal of Molecular Sciences
Volume 21
Issue 19
International Journal of Molecular Sciences, Vol 21, Iss 7391, p 7391 (2020)
Volume 21
Issue 19
International Journal of Molecular Sciences, Vol 21, Iss 7391, p 7391 (2020)
Intervertebral disc (IVD) degeneration is one of the predominant causes of chronic low back pain (LBP), which is a leading cause of disability worldwide. Despite substantial progress in cell therapy for the treatment of IVD degeneration, significant